Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

Historical Holders from Q2 2021 to Q3 2025

Symbol
CNTA on Nasdaq
Type / Class
Equity / Ordinary shares, par value 0.002 GBP per share
Shares outstanding
147,336,360
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
128,332,503
Holdings value
$3,111,987,564
% of all portfolios
0.009%
Number of holders
124
Number of buys
57
Number of sells
-69
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 8.06% $262,095,940 10,808,080 Avoro Capital Advisors LLC 30 Sep 2025
Adage Capital Management, L.P. 7.48% +19.8% $243,348,750 +$39,576,000 10,035,000 +19.4% Adage Capital Management, L.P. 30 Sep 2025
General Atlantic Cooperatief U.A. 5% -22.9% $180,192,368 -$56,624,900 7,366,818 -23.9% General Atlantic Cooperatief U.A. 25 Nov 2025
FMR LLC 7% $152,223,143 6,277,243 FMR LLC 30 Sep 2025

Institutional Holders of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 128,332,503 $3,111,987,564 +$147,803,679 $24.25 124
2025 Q2 123,569,478 $1,623,678,828 -$30,690,539 $13.14 117
2025 Q1 124,913,742 $1,797,461,231 -$6,439,160 $14.38 130
2024 Q4 124,413,136 $2,083,915,345 +$72,898,202 $16.75 114
2024 Q3 108,571,980 $1,737,489,847 +$315,516,266 $15.99 101
2024 Q2 86,506,981 $781,158,600 +$108,671,569 $9.03 79
2024 Q1 74,395,267 $840,663,455 +$66,659,727 $11.3 69
2023 Q4 71,279,084 $567,382,245 +$15,317,885 $7.96 56
2023 Q3 72,578,425 $469,582,127 +$14,480,766 $6.47 46
2023 Q2 70,339,619 $435,403,089 +$25,413,534 $6.19 43
2023 Q1 66,895,058 $257,540,618 +$13,125,714 $3.85 42
2022 Q4 62,684,642 $194,353,719 +$5,918,047 $3.1 41
2022 Q3 71,808,783 $288,649,039 -$842,289 $4.02 41
2022 Q2 71,775,040 $349,577,531 -$37,633,222 $4.87 40
2022 Q1 74,581,035 $669,057,512 +$23,146,015 $8.97 40
2021 Q4 71,873,880 $807,766,000 +$18,577,946 $11.26 46
2021 Q3 52,983,439 $881,813,000 +$147,088,157 $16.7 38
2021 Q2 47,409,892 $1,045,414,000 +$1,045,413,999 $22.21 49